Nonviral targeted mRNA delivery: principles, progresses, and challenges
MedComm · 2025-01 · 6 (1)
DOI: 10.1002/mco2.70035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 02.01.2025. Verfasst von Xi He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Messenger RNA (mRNA) therapeutics have garnered considerable attention due to their remarkable efficacy in the treatment of various diseases. The COVID‐19 mRNA vaccine and RSV mRNA vaccine have been approved on the market. Due to the inherent nuclease‐instability and negative charge of mRNA, delivery systems are developed to protect the mRNA from degradation and facilitate its crossing cell membrane to express functional proteins or peptides in the cytoplasm. However, the deficiency in transfection efficiency and targeted biological distribution are still the major challenges for the mRNA delivery systems. In this review, we first described the physiological barriers in the process of mRNA delivery and then discussed the design approach and recent advances in mRNA delivery systems with an emphasis on their tissue/cell‐targeted abilities. Finally, we pointed out the existing challenges and future directions with deep insights into the design of efficient mRNA delivery systems. We believe that a high‐precision targeted delivery system can greatly improve the therapeutic effects and bio‐safety of mRNA therapeutics and accelerate their clinical transformations. This review may provide a new direction for the design of mRNA delivery systems and serve as a useful guide for researchers who are looking for a suitable mRNA delivery system.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
- State Key Laboratory of Quality Research in Chinese Medicine Macau Institute for Applied Research in Medicine and Health Macau University of Science and Technology Taipa Macau China.
ORCID-Profile: Xi He
Förderung
- National Key Research and Development Program of China
Zitieren
APA
He, X., Li, G., Huang, L., Shi, H., Zhong, S., Zhao, S., Jiao, X., Xin, J., Yin, X., Liu, S., He, Z., Guo, M., Yang, C., Jin, Z., Guo, J., & Song, X. (2025). Nonviral targeted mRNA delivery: principles, progresses, and challenges. MedComm, 6(1). https://doi.org/10.1002/mco2.70035
Vancouver
He X, Li G, Huang L, Shi H, Zhong S, Zhao S, et al. Nonviral targeted mRNA delivery: principles, progresses, and challenges. MedComm. 2025;6(1). doi:10.1002/mco2.70035
BibTeX
@article{He2025,
author = {He, Xi and Li, Guohong and Huang, Letao and Shi, Haixing and Zhong, Sha and Zhao, Siyu and Jiao, Xiangyu and Xin, Jinxiu and Yin, Xiaoling and Liu, Shengbin and He, Zhongshan and Guo, Mengran and Yang, Chunli and Jin, Zhaohui and Guo, Jun and Song, Xiangrong},
title = {Nonviral targeted mRNA delivery: principles, progresses, and challenges},
journal = {MedComm},
year = {2025},
volume = {6},
number = {1},
doi = {10.1002/mco2.70035}
}
EUVIMED